350: Dan Heath | Solving Problems from Upstream

Prevention Costs

The financial paradox of prevention is a significant challenge in implementing upstream solutions. Dan Heath highlights how prevention programs, like the Diabetes Prevention Program, face funding hurdles despite their proven effectiveness in reducing diseases like diabetes 1. He argues that the focus on cost savings as a justification for prevention is misguided, emphasizing that the true value lies in the ethical imperative to prevent harm 1. Heath also discusses the Nurse-Family Partnership, which demonstrates a high return on investment but struggles with funding due to the "wrong pocket problem," where benefits are dispersed across various sectors 2.

There's no law that says for a prevention program to be worth doing, it has to save us some coin.

--- Dan Heath

This complexity underscores the need for a broader perspective on the benefits of prevention beyond mere cost savings.

   

Healthcare Economics

Healthcare in the US exemplifies the economic challenges of upstream thinking. Jordan Harbinger and Dan discuss how the US excels in treating diseases but lags in prevention, contrasting with countries like Norway that invest more in upstream health measures 3. Dan points out the unsustainable nature of current healthcare spending, where significant funds are allocated to treating chronic diseases rather than preventing them 4. He highlights the need for smarter trade-offs, such as investing in preventive measures to reduce long-term healthcare costs.

We won't think anything of spending $40,000 a year for the price of insulin, but we'll balk at paying $1,000 to try to prevent someone from getting diabetes.

--- Dan Heath

This discussion reveals the potential for policy shifts that prioritize prevention to improve health outcomes and reduce costs.